Int J Biol Sci 2012; 8(4):533-547. doi:10.7150/ijbs.3753
Isoalantolactone Induces Reactive Oxygen Species Mediated Apoptosis in Pancreatic Carcinoma PANC-1 Cells
1. Central Research Laboratory, Jilin University Bethune Second Hospital, Changchun 130041, P. R. China;
2. Membrane Channel Research Laboratory, Northeast Normal University, Changchun 130024, P. R. China.
Khan M, Ding C, Rasul A, Yi F, Li T, Gao H, Gao R, Zhong L, Zhang K, Fang X, Ma T. Isoalantolactone Induces Reactive Oxygen Species Mediated Apoptosis in Pancreatic Carcinoma PANC-1 Cells. Int J Biol Sci 2012; 8(4):533-547. doi:10.7150/ijbs.3753. Available from https://www.ijbs.com/v08p0533.htm
Isoalantolactone, a sesquiterpene lactone compound possesses antifungal, antibacteria, antihelminthic and antiproliferative activities. In the present study, we found that isoalantolactone inhibits growth and induces apoptosis in pancreatic cancer cells. Further mechanistic studies revealed that induction of apoptosis is associated with increased generation of reactive oxygen species, cardiolipin oxidation, reduced mitochondrial membrane potential, release of cytochrome c and cell cycle arrest at S phase. N-Acetyl Cysteine (NAC), a specific ROS inhibitor restored cell viability and completely blocked isoalantolactone-mediated apoptosis in PANC-1 cells indicating that ROS are involved in isoalantolactone-mediated apoptosis. Western blot study showed that isoalantolactone increased the expression of phosphorylated p38 MAPK, Bax, and cleaved caspase-3 and decreased the expression of Bcl-2 in a dose-dependent manner. No change in expression of phosphorylated p38 MAPK and Bax was found when cells were treated with isoalantolactone in the presence of NAC, indicating that activation of these proteins is directly dependent on ROS generation. The present study provides evidence for the first time that isoalantolactone induces ROS-dependent apoptosis through intrinsic pathway. Furthermore, our in vivo toxicity study demonstrated that isoalantolactone did not induce any acute or chronic toxicity in liver and kidneys of CD1 mice at dose of 100 mg/kg body weight. Therefore, isoalantolactone may be a safe chemotherapeutic candidate for the treatment of human pancreatic carcinoma.
Keywords: Isoalantolactone, PANC-1, ROS, Apoptosis, NAC.
Pancreatic cancer is the fourth most common cause of cancer-related deaths in United States . Despite advancements in diagnosis, surgery, radiotherapy and chemotherapy, the overall 5 year survival rate remains less than 3 years while the median survival rate is about 6 months . Surgical abscission remains the only option for long term survival of patients. However, difficulty in achieving early diagnosis and aggressive nature of this type of cancer limit the surgical operation to only about 10% patients. Therefore, the majority of pancreatic cancer patients are treated with chemotherapy . Currently, gemcitabine (Gem) is the most effective chemotherapeutic drug for pancreatic cancer. However, even with this drug, the overall survival rate remains considerably low. Moreover, Gem is highly toxic to tumor cells as well as normal cells [4, 5]. Several other cytotoxic and chemotherapy agents such as cisplatin, fluorouracil, docetaxel and irinotecan have been tested as single agent or in combination with gemcitabine for pancreatic cancer, however most of these studies failed to ameliorate overall patient survival compared to gemcitabine . Furthermore, most of these drugs have been shown to cause severe hepatotoxicity . As pancreatic cancer responds poorly to the existing conventional chemotherapy, therefore it is important to study the anti-pancreatic cancer mechanism using newly identified effective anticancer compounds that exhibit low toxicity on normal cells.
A number of recent reports indicated that phytochemicals targeting ROS metabolism can selectively kill the cancer cells by raising the level of ROS above a toxic threshold. As cancer cells contain higher level of endogenous ROS than normal cells, the toxic threshold can be easily achieved in cancer cells compared to normal cells [7, 8]. In the present study, we performed high throughput screening of compound library from Chinese herbs, using pancreatic cancer cell line PANC-1, in the presence or absence of NAC, a specific ROS inhibitor. This screening method allowed us to identify anti-pancreatic cancer compounds targeting ROS metabolism. Isoalantolactone, a sesquiterpene lactone compound was identified as a potent inhibitor of pancreatic carcinoma cells during screening process. Sesquiterpene lactones are plant-derived compounds used in the manufacture of traditional medicines for the treatment of inflammatory diseases, headache and infections . Over the past few years, a large body of pharmacological studies has provided convincing evidences of the anticancer property of sesquiterpene lactones against various human cancer cell lines [10, 11]. At present, several sesquiterpene lactone compounds are in cancer clinical trials against breast, colorectal, kidney, prostate, acute myeloid leukemia, acute lymphoblastic leukemia, and non small lung cancer treatment . However, the anti-pancreatic cancer potential of sesquiterpene lactone compounds is not well studied.
Isoalantolactone is one of the major sesquiterpene lactone compounds, isolated from the roots of Anula helenium and possesses multiple biological activities including antibacteria, antifungal, antihelminthic and antiproliferative . The above findings encouraged us to study the anti-pancreatic cancer potential of isoalantolactone as well as its toxicity on normal cells in vitro and hepatotoxicity and nephrotoxicity in vivo.
Materials and Methods
Isoalantolactone (IALT) was purchased from Tauto Biotech Co., Ltd. (Shanghai, China) and purity (> 99%) was determined by HPLC. RNase A, Propidium iodide (PI), calcein acetoxymethylester (Calcein AM), Hoechst 33258, 10-Nnonyl Acridine Orange (NAO), Dimethyl Sulfoxide (DMSO), [3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide] (MTT), Dulbecco's Modified Eagle's Medium (DMEM), DMEM/F12 medium, fatal bovine serum (FBS), penicillin and streptomycin were purchased from Sigma (Beijing, China). Apoptosis assay kit, Reactive oxygen species kit, JC-1, and Antibodies specific to p-p38 MAPK, Bax, Bcl-2, cytochrome c, and caspase-3 were purchased from Beyotime institute of Technology (Shanghai, China). Antibodies specific to β-actin and horseradish peroxidase-conjugated secondary antibodies (goat-anti-rabbit, goat-anti-mouse) were purchased from Santa Cruz (Beijing, China).
Cell Culture and Treatments
The human pancreatic carcinoma PANC-1, BxPC3, HPAC cells and monkey non-tumorigenic COS-7 cells were obtained from Shanghai Cell Bank. PANC-1, BxPC3 and COS-7 cells were cultured in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% fatal bovine serum (FBS), 100 units/mL penicillin and 100 µg/mL streptomycin whereas HPAC cells were cultured in DMEM/F12 medium supplemented with 10% (FBS), 100 units/mL penicillin and 100 µg/mL streptomycin and maintained at 37°C with 5% CO2 in humidified atmosphere. Cells were treated with various concentrations of isoalantolactone dissolved in DMSO with a final DMSO concentration of 1% for 24 h. DMSO treated cells were used as control.
Determination of Cell Viability
Cell viability was assessed by MTT assay as described previously . Briefly PANC-1, BxPC3, and HPAC cells were treated with dimethyl sulfoxide (DMSO) or isoalantolactone in the presence or absence of 3 mM NAC for 24 h. Following treatment, the MTT reagent was added (500µg/mL) and cells were further incubated at 37°C for 4 h. Subsequently 150 μL DMSO was added to dissolve farmazan crystals and absorbance was measured at 570 nm in a microplate reader (Thermo Scientific). The percentage of cell viability was calculated as follows:
Cell viability (%) = (A570sample - A570blank) / (A570control - A570blank)×100
The IC50 Values were calculated using GraphPad Prism 5.
Live and dead cells were quantified using the fluorescent probes calcein acetoxymethylester (calcein AM) and propidium iodide (PI). Celcein AM is cell membrane permeable and stains only viable cells whereas PI is cell membrane impermeable and stains only dead cells. To determine the effect of isoalantolactone on cancer cells and normal cells, pancreatic carcinoma cells (PANC-1) and normal cells (COS-7) were treated with 20 and 40 µM isoalantolactone in the presence or absence of NAC for 24 h. Subsequently, treated and untreated cells were collected, washed with phosphate buffered saline (PBS) and incubated with PBS solution containing 2 µM calcein AM and 4 µM PI in the dark for 20 min at room temperature. After washing, cells were resuspended in PBS and analyzed for the fluorescence of calcein and PI by flow cytometry (Beckman Coulter, Epics XL).
Apoptosis assay by Annexin V-FITC and propidium iodide (PI) staining
PANC-1 cells were treated with isoalantolactone in a dose- and time-dependent manner in the presence or absence of 3 mM NAC. After treatment, cells were harvested, washed with PBS, and resuspended in 200 µL of binding buffer containing 5 µL Annexin V and put in the dark for 10 min according to the kit instructions (Beyotime, Shanghai, China). After incubation, cells were labeled with 10 µL PI and samples were immediately analyzed by flow cytometry (Beckman Coulter, Epics XL).
Hoechst 33258 staining for Nuclei Condensation and Fragmentation
PANC-1 cells were treated with 40 µM isoalantolactone for various time points (0, 4, 12, and 24 h). The cells were fixed with 4% paraformaldehyde for 30 min at room temperature. After washing with PBS, cells were stained with Hoechst 33258 (50 µg/mL) at 37°C for 20 min in the dark. At the end, the cells were washed and resuspended in PBS for the observation of nuclear morphology under fluorescence microscope (Olympus 1x71).
Cell cycle analysis
PANC-1 cells were treated with 20 and 40 µM isoalantolactone for 24 h. After treatment, cells were harvested, washed with PBS and fixed with 70% ethanol at 4°C for overnight. After washing twice with PBS, cells were stained with a solution containing 50 μg/mL PI and 100 μg/mL RNase A for 30 min in the dark at room temperature. The DNA contents for cell cycle phase distribution were analyzed by flow cytometry (Beckman Coulter, Epics XL) using Cell Quest software.
Measurement of Reactive Oxygen Species (ROS)
The intracellular changes in ROS generation were measured by staining the cells with 2', 7' -dichlorofluorescein-diacetate (DCFH-DA) as described previously . The fluorescent dye DCFH-DA is a cell membrane permeable and is converted into cell membrane impermeable nonfluorescent compound DCFH by intracellular esterases. Oxidation of DCFH by reactive oxygen species produces a highly fluorescent DCF. The fluorescence intensity of DCF inside the cells is proportional to the amount of peroxide produced. Briefly PANC-1 cells were treated with 20 and 40 µM isolantolactone for 24 h. After treatment, cells were further incubated with 10 μM DCFH-DA at 37°C for 30 min. Subsequently, cells were harvested, rinsed, re-suspended in PBS, filtered with 300 apertures and analyzed for 2', 7' -dichlorofluorescein (DCF) fluorescence by flow cytometry.
Measurement of Mitochondrial Membrane Lipid Peroxidation
Mitochondrial membrane lipid peroxidation was determined by measuring the oxidation of intracellular cardiolipin by staining the cells with 10-N-nonyl acridine orange (NAO), a probe specific for mitochondrial membrane cardiolipin . Briefly PANC-1 cells were treated with 20 and 40 µM isoalantolactone for 24 h. After washing with PBS, cells were further incubated with 5 µM NAO in the dark at room temperature for 30 min. After washing, samples were analyzed by flow cytometry.
Measurement of Mitochondrial Membrane Potential (MMP)
MMP was determined using JC-1 probe (Beyotime) as described previously [15, 16]. JC-1 is widely used to monitor mitochondrial membrane depolarization. In healthy cells with high mitochondrial membrane potential, JC-1 spontaneously forms complexes known as J-aggregates with intense red fluorescence. Whereas, in apoptotic or unhealthy cells with low mitochondrial membrane potential, JC-1 remains in the monomeric form, which shows only green fluorescence. Thus mitochondrial depolarization is indicated by a decrease in red/green fluorescence intensity ratio. Briefly after treating the cells with 20 and 40 µM isoalantolactone for 24 h, cells were stained with 10 µM of JC-1 for 25 min at 37°C. After washing, cells were analyzed for the decrease in red/green fluorescence by flow cytometry.
Proteins were isolated from control and isoalantolactone-treated cells as described previously . 40 µg proteins were electrophoresed on 10% SDS-PAGE and transferred to PVDF membrane. After blocking with 5% (w/v) non-fat milk and washing with Tris-buffered saline-Tween solution (TBST), membranes were incubated overnight at 4°C with p-p38 MAPK (1:1000), Bcl-2 (1:1000), Bax (1:300), cytochrome c (1:200), caspase-3 (1:500) and β-actin (1:400) antibodies respectively. After washing, the blots were incubated with horseradish peroxidase-conjugated goat anti-rabbit IgG or goat anti-mouse IgG secondary antibodies (1:5000) for 1 h at room temperature. After washing with TBST, signals were detected using ECL plus chemiluminescence kit on X-ray film (Millipore Corporation). All the bands obtained were quantified by densitometry using Image J software.
In Vivo Studies
In vivo studies for acute and chronic toxicity were conducted on 10-12 week old CD1 mice weighing 27-30 g. The mice were maintained in a specific pathogen-free grade animal facility on a 12-h light/dark cycles at 25±2°C. Mouse procedures were approved by the Experimental Animal Committee of Jilin University. Mice were randomly divided into four groups. Group A (n = 4) administered with 50 µL DMSO intraperitonially for 7 days; Group B (n = 4) administered with isoalantolactone (100 mg/kg body weight) in 50 µL DMSO intraperitonially for 7 days; Group C (n = 4) administered with 50 µL DMSO for 30 days and Group D (n = 4) administered with isoalantolactone (100 mg/kg body weight) in 50 µL DMSO intraperitonially for 30 days.
At the first and last day of the experiments, the body weight of each mouse was measured. At the end of experiments (at dose day 7 for acute toxicity & dose day 30 for chronic toxicity), mice were anesthetized using Pentobarbital sodium (50 mg/kg ip), blood was collected via cardiac puncture, allowed to clot for 10 min and centrifuge at 1000×g for 10 min at room temperature. Serum was separated and stored at -20°C until analysis. The liver and kidneys were excised and processed for hematoxylin and eosin staining followed established procedures.
Serum Biomarker Analysis
The acute and chronic toxicity of isoalantolactone on liver and kidneys was determined by measuring the serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), total bilirubin (TBIL), blood urea nitrogen (BUN) and creatinine (Cr) using blood auto analyzer (Hitechi 7170).
The results are expressed as Mean ± SEM and statistically compared with control group or within the groups using one way ANOVA followed by Tukey's Multiple Comparison Test. Student's T-test was used to determine significance when only two groups were compared and p<0.05 was considered statistically significant.
Isoalantolactone Inhibibited Pancreatic Cancer Cells Growth in Vitro
The cytotoxic effect of isoalantolactone on pancreatic carcinoma was evaluated using PANC-1, BxPC3 and HPAC cell lines. Treatment with isoalantolactone for 24 h inhibited PANC-1 cell growth in a dose-dependent manner (Fig 1A). The inhibition rate was above 90% at 80 µM and the concentration to achieve 50% growth inhibition (IC50) was 40 µM. A similar trend in loss of cell viability was observed in BxPC3 and HPAC cells on isoalantolactone treatment with IC50 values 43 and 48 µM respectively (Fig. 1B & C). Pretreatment with 3 mM NAC, a specific ROS scavenger, restored the viability of cells indicating that isoalantolactone exerts cytotoxic effect on cell viability through ROS generation. PANC-1 cell line was found more sensitive to isoalantolactone and selected for further mechanistic study.
Cancer Cells are more sensitive to Isoalantolactone than Normal cells
The cytotoxic effect of isoalantolactone on PANC-1 cells was further confirmed by live/dead assay. Apart from cancer cells, the cytotoxic effect of isoalantolactone on normal cells (COS-7 cells) was also evaluated. For this purpose, pancreatic carcinoma cells (PANC-1) and normal cells (COS-7) were treated with 20 and 40 µM isoalantolactone for 24 h and live and dead cells were quantified using fluorescent probes calcein AM/PI and flow cytometry. The data showed that treatment of cells with isoalantolactone reduced the viability of PANC-1 and COS-7 cells in a dose-dependent manner. However, the viability of COS-7 cells was significantly higher than PANC-1 cells after exposure to 20 and 40 µM isoalantolactone for 24 h (Fig 2). Next, to examine whether ROS scavenger, NAC protects the cells from cytotoxic effect of isoalantolactone, PANC-1 and COS-7 cells were incubated with 40 µM isoalantolactone in the presence of 3 mM NAC for 24 h and cell viability was determined by live/dead assay. The data demonstrated that NAC completely abolished isoalantolactone-induced cytotoxic effect in PANC-1 as well as in COS-7 cells. The data indicate that isoalantolactone-induced cytotoxicity in PANC-1 as well as in COS-7 cells is associated with generation of intracellular ROS. The differential toxicity of isoalantolactone between normal cells and cancer cells may be due to much lower level of endogenous ROS in normal cells than cancer cells.
Isoalantolactone induces Apoptosis and S phase Arrest in PANC-1 Cells
Apoptosis and cell cycle arrest are two major causes of cell growth inhibition. The effect of isoalantolactone on cell apoptosis was analyzed by Annexin V-FITC/PI staining using flow cytometry and Hoechst 33258 staining using fluorescence microscope. The results showed that isoalantolactone induced apoptosis in PANC-1 cells in a dose- and time-dependent manner. Treatment of cells with 20 and 40 µM isoalantolactone significantly increased apoptosis rate (62.67±2.82 and 69±4.23 vs 2.88±0.59 in control, P<0.01) (Fig. 3A). Pretreatment with NAC completely blocked the apoptotic effect of isoalantolactone indicating that induction of apoptosis is ROS-dependent. Next, we treated the cells with 40 µM isoalantolactone and level of ROS and apoptosis rates were observed at different time points. The data demonstrated that isoalantolactone induced apoptosis (Fig. 3B) and ROS generation (Data not shown) in PANC-1 cells in a time-dependent manner. The isoalantolactone-induced apoptosis was also identified using Hoechst 33258 staining and fluorescence microscope at different time points. In the control group, the nuclei were round and stained homogeneously whereas isoalantolactone-treated cells showed condensed and marked fragmented nuclei in a time-dependent manner (Fig. 4). Taken together, the data demonstrate that isoalantolactone induces apoptosis in PANC-1 cells in a dose- and time-dependent manner which is correlated with ROS generation.
Effect of isoalantolactone on PANC-1, BxPC3 and HAPC cells viability. Cells were treated with different concentrations of isoalantolactone in the presence or absence of NAC for 24 h and cell viability was measured by MTT assay. (A) PANC-1 cells were treated with various concentrations of isoalantolactone for 24 h. (B) BxPC3 cells were treated with various concentrations of isoalantolactone for 24 h. (C) HPAC cells were treated with various concentrations of isoalantolactone for 24 h. Data are expressed as Mean ± SEM (n=3). Columns not sharing the same superscript letter differ significantly (P<0.05).(Click on the image to enlarge.)
Determination of cell viability by Calcein/PI staining and Flow Cytometry (A) PANC-1 cells were treated with 20 and 40 µM isoalantolactone in the presence or absence of NAC for 24 h. (A1) Control, (A2) 20 µM, (A3) 40 µM, (A4) 40 µM isoalantolactone + 3 mM NAC. (B) COS-7 cells were treated with 20 and 40 µM isoalantolactone in the presence or absence of NAC for 24 h. (B1) Control, (B2) 20 µM, (B3) 40 µM, (B4) 40 µM isoalantolactone + 3 mM NAC. (C) Data are expressed as Mean ± SEM (n=3). Columns not sharing the same superscript letter differ significantly (P<0.05).(Click on the image to enlarge.)
Induction of cell cycle arrest was analyzed using PI staining and flow cytometry. Our results showed that isoalantolactone arrested the cell cycle at S phase in a dose-dependent manner. Treatment with isoalantolactone at 20 and 40 µM showed a significant increase in S phase from 19.73±1.94 to 31±1.53 & 49.23±1.43 with a corresponding decrease in G0/G1 phase from 59.48±3.43 to 56.13±1.82 & 47.36±0.91 and G2/M phase from 22.5±1.21 to 13.16±0.78 & 3.26±0.69 respectively at P<0.05 (Fig. 5).
Isoalantolactone induces Increased Generation of ROS in PANC-1 Cells
Intracellular ROS generation in PANC-1 cells was evaluated by flow cytometry using DCFH-DA. As shown in Fig. 6A, the level of ROS in PANC-1 cells, treated with 20 and 40 µM isoalantolactone was significantly higher (21.33±1.45 & 33.0±1.73 vs 1.02±0.47 in control group, P<0.05).
Isoalantolactone causes Cardiolipin Oxidation (CL oxidation) and Disrupt Mitochondrial Membrane Potential (MMP) in PANC-1 Cells
Reactive oxygen species once generated cause massive oxidation of redox sensitive proteins and lipids leading to mitochondrial damage. Next we asked if isoalantolactone can cause mitochondrial cardiolipin (CL) oxidation. Cardiolipin is exclusively found in mitochondria and cytochrome c is bound to cardiolipin. Oxidation of cardiolipin results in liberation of cytochrome c from mitochondrial membrane. To examine CL oxidation, cells were stained with NAO, and CL oxidation was determined by flow cytometry. The data showed that isoalantolactone caused CL oxidation in PANC-1 cells in a dose-dependent manner (Fig. 6B).
Flow cytometry analysis of apoptosis in PANC-1 cells treated with isoalantolactone in a dose- and time-dependent manner in the presence or absence of 3 mM NAC. (A) PANC-1 cells were treated with 20 and 40 µM isoalantolactone in the presence or absence of NAC for 24 h. (A1) Control, (A2) 20 µM, (A3) 40 µM, (A4) 40 µM isoalantolactone + 3 mM NAC, (A5) Data are expressed as Mean ± SEM (n=3). Columns not sharing the same superscript letter differ significantly (P<0.05). (B) PANC-1 cells were treated with 40 µM isoalantolactone for various time intervals. (B1) Control, (B2, B3 and B4) PANC-1 cells were treated with 40 µM isoalantolactone for 4, 8 and 12 h respectively. (B5) Data are expressed as Mean ± SEM (n=3). Columns not sharing the same superscript letter differ significantly (P<0.05).(Click on the image to enlarge.)
Induction of apoptosis by isoalantolactone in PANC-1 cells using Hoechst 33258 staining and fluorescence microscope. PANC-1 cells were treated with 40 µM isoalantolactone for various time intervals and nuclear morphological changes were observed using Hoechst 33258 staining and fluorescence microscope. The cells treated with 40 µM isoalantolactone for various time intervals exhibited apoptotic changes such as condensed chromatin and fragmented nuclei as indicated by arrows. (A) Control, (B, C, and D) Cells were treated with 40 µM isoalantolactone for 4, 12 and 24 h respectively. Cell were fixed with 4% paraformaldehyde, washed with PBS, resuspended in PBS and observed under fluorescence microscope for nuclear morphological changes. Scale bar = 20 µm.(Click on the image to enlarge.)
Flow cytometry analysis of cell cycle phase distribution in PANC-1 cells treated with 20 and 40 µM isoalantolactone for 24 h. (A) Control, (B) 20 µM, (C) 40 µM. (D) Data are expressed as Mean ± SEM (n=3). Columns not sharing the same superscript letter differ significantly (P<0.05)(Click on the image to enlarge.)
Flow cytometry analysis of ROS generation (A) and Cardiolipin oxidation (B) in PANC-1 cells treated with 20 and 40 µM IALT in the presence or absence of 3 mM NAC for 24 h. (A1) Control, (A2) 20 µM, (A3) 40 µM, (A4) 40 µM isoalantolactone + 3 mM NAC, (A5) Data are expressed as Mean ± SEM (n=3). Columns not sharing the same superscript letter differ significantly (P<0.05). (B1) Control, (B2) 20 µM, (B3) 40 µM, (B4) 40 µM isoalantolactone + 3 mM NAC, (B5) Data are expressed as Mean ± SEM (n=3). Columns not sharing the same superscript letter differ significantly (P<0.05)(Click on the image to enlarge.)
Depolarization in MMP is a characteristic feature of apoptosis. Excessive intracellular ROS production has been shown to induce apoptosis by disrupting MMP [16, 17]. To investigate the role of ROS in isoalantolactone-mediated apoptosis, we determined MMP in PANC-1 cells using JC-1 and flow cytometry. As shown in Fig. 7, MMP in cells treated with 20 and 40 µM isoalantolactone was significantly lower (89.43±1.75% & 84.40±0.92% vs 98.03±0.55% in control group, P<0.05). To further confirm the involvement of ROS in CL oxidation and disruption of MMP, cells were treated with 3 mM NAC. Pretreatment with NAC completely prevented CL oxidation and drop in MMP, indicating that both these processes are ROS-dependent.
Effect of Isoalantolactone on Major Mitochondrial Apoptosis Regulatory Proteins
To further characterize mitochondrial apoptosis in detail, the effect of isoalantolactone on the expression of some major proteins (p38 MAPK, Bax, Bcl-2, cytochrome c and caspase-3) involved in mitochondrial apoptosis pathway was determined by Western blot analysis. Previous studies have shown that increased intracellular ROS generation can activate p38 MAP kinase  and activated p38 MAPK plays important role in activation and translocation of Bax which ultimately results in release of cytochrome c and activation of caspase-3 [19, 20]. To observe whether p38 MAP kinase is activated by isoalantolactone, we checked the expression of p38 MAPK using a phosphospecific antibody recognizing active p38 MAPK by Western blot analysis. The results showed an increased expression of phosphorylated p38 MAPK in isoalantolactone-treated cells (Fig. 8A).
Flow cytometry analysis of mitochondrial membrane potential in PANC-1 cells treated with 20 and 40 µM isoalantolactone in the presence or absence of 3 mM NAC for 24 h. (A) Control, (B) 20 µM, (C) 40 µM, (D) 40 µM IALT + 3 mM NAC, (E) Data are expressed as Mean ± SEM (n=3). Columns not sharing the same superscript letter differ significantly (P<0.05).(Click on the image to enlarge.)
Effect of isoalantolactone on the expression of major apoptosis regulatory proteins (A) PANC-1 cells were treated with 20 and 40 µM isoalantolactone for 24. The expressions of p-p38, Bcl-2, Bax, cytochrome c and caspase-3 were determined by Western blotting and quantified by Image J software. (B) PANC-1 cells were treated with 20 and 40 µM isoalantolactone in the presence of 3 mM NAC for 24 h. The expressions of p-p38 and Bax were determined by Western blot analysis and quantified by Image J software. (C) Data are expressed as Mean ± SEM (n=3). Columns not sharing the same superscript letter within the group differ significantly (P<0.05)(Click on the image to enlarge.)
To further investigate, we analyzed the expression of Bax, Bcl-2, cytochrome c and caspase-3 in PANC-1 cells after exposure to 20 and 40 µM isoalantolactone for 24 h. As shown in Fig. 8A, isoalantolactone treatment increased the expression of Bax and decreased the expression of Bcl-2 accompanied by the release of cytochrome c from mitochondria to cytosol and caspase-3 activation in a dose-dependent manner. To investigate whether increased ROS generation is functionally linked to isoalantolactone-induced p38 MAPK and Bax activation, we observed the expressions in the cell lysates treated with isoalantolactone in the presence of NAC. No change in the expression levels of p38 MAPK and Bax was observed, further confirming that activation of both these proteins is ROS-dependent (Fig. 8B).
Isoalantolactone Exerts no Toxic Effect on Liver and Kidneys in Vivo
The acute and chronic toxic effects of isoalantolactone in CD1 mice were assessed by measuring the changes in body weight, blood biochemistry and histopathology of liver and kidneys in comparison with control groups.
The drug was well tolerated by mice and no mortality or any sign of pharmacotoxicity were found at a dose of 100 mg/kg during both experimental periods (7 & 30 days). Body weight gains and food consumption were comparable for control and treated mice during both experimental periods and there were no drug-related changes in histopathological and blood biochemistry parameters. The histopathological changes in liver and kidneys were assessed using hematoxylin and eosin staining and correlated with liver and renal function biomarkers. No obvious morphological changes were observed in liver and kidney structures of control and treatment groups (Fig 9). These results were further confirmed by measuring the changes in liver function biomarkers (AST, ALT and TBIL) and renal function biomarkers (BUN and Cr) in the serum of control and treatment groups. As shown in Table 1, there was a slight increase in serum ALT and AST level of treatment group at dose day 7 but this increase was not significantly different (P<0.05) from control group. However, a significant increase in TBIL concentration was found in treatment group (1.43±0.26 vs 0.76±0.12 in control, P<0.05) at dose day 7. Similarly the changes in renal function biomarkers (Cr & BUN) were not significantly different (P<0.05) in the serum of control and treatment groups at dose day 7. The concentration of Cr slightly increased whereas concentration of BUN slightly decreased in treatment group (Table 1). Interestingly, the serum level of AST, ALT, TBIL and BUN slightly decreased when mice were injected with isoalantolactone at a dose of 100 mg/kg for 30 days (Table 1). However, these alterations do not differ significantly from control group (P<0.05).
Hematoxylin & Eosin stained sections of Kidney and Liver from CD1 mice administered with vehicle or isoalantolactone at a dose of 100 mg/kg body weight. The liver and kidneys from control and IALT-treated mice were excised and processed for hematoxylin and eosin staining followed established procedures. (A) Kidney section; Scale bar = 100 µm. (B) kidneys sections representing structure of glomeruli; Scale bar = 20 µm. (C) Liver section; Scale bar = 20 µm.(Click on the image to enlarge.)
Biochemical effect of isoalantolactone on Liver and Kidneys function Biomarkers in CD1 mice.
|Groups||Body Weight (g)||ALT|
Data are expressed as Mean ± SEM, n = 4
* Significantly different from control, p<0.05
Group A & B were daily given 50 µL DMSO and isoalantolactone (100 mg/kg) for 7 days respectively.
Group C & D were daily given 50 µL DMSO and isoalantolactone (100 mg/kg) for 30 days respectively.
Previous studies have indicated that root extract of Inula helenium has inhibitory activity against various cancer cell lines [21, 22]. One recent study by Pal et al. has shown that Inula recemosa extract containing alantolactone and isoalantolactone induces apoptosis and increased ROS generation in HL-60 cells . However, the role of ROS remained undefined. In the present study, we addressed the question of whether or not isoalantolactone could induce apoptosis and increase ROS generation in PANC-1 cells. To address the question, we examined the antiproliferative, apoptotic and ROS generating ability of isoalantolactone using MTT assay and flow cytometry. The results showed that isoalantolactone inhibited growth of PANC-1 cells and induced apoptosis and ROS generation in a dose-dependent manner. To probe the possible role of ROS, we performed MTT assay, Live/dead assay and apoptosis assay in the presence of a specific ROS inhibitor, NAC. The results showed that pretreatment with NAC restored cell viability and blocked the apoptotic effect of isoalantolactone completely. The data demonstrate clearly that isoalantolactone exerts its growth inhibitory effect through ROS generation. The present study provides evidence for the first time that isoalantolactone induces ROS-dependent apoptosis in PANC-1 cells.
Over production of ROS results in oxidative damage including; lipid peroxidation, protein oxidation and DNA damage. In addition, ROS are known to act as second messengers to activate diverse redox-sensitive signalling cascades including mitochondrial intrinsic apoptotic cascade through interaction with Bcl-2 family proteins, MAPK family member p38 and its downstream transcription factors [17, 23-25]. Bcl-2 family proteins include a wide variety of anti-apoptotic proteins such as Bcl-2 and pro-apoptotic proteins such as Bax, which are key players of mitochondrial outer membrane permeabilization and apoptosis regulation [26, 27]. ROS have been shown to inhibit anti-apoptotic protein Bcl-2 and activate and translocate pro-apoptotic protein Bax to outer mitochondrial membrane (OMM) where it forms oligomers, which are thought to be important in the formation of permeability transition pores (PTP) and cytochrome c release. Some other studies have shown that ROS activate p38 MAPK  and activated p38 MAPK promotes the activation and translocation of Bax to OMM [25, 28].
In the present study, isoalantolactone increased ROS production in PANC-1 cells in a time- and dose-dependent manner. To investigate whether isoalantolactone can trigger intrinsic apoptotic cascade in PANC-1 cells, we examined the expression of Bcl-2, p38 MAPK and Bax proteins in the cells of each group using Western blot analysis. The results demonstrated that expression of Bcl-2 gradually decreased while expression of p38 MAPK and Bax increased in cells of treatment groups in a dose-dependent manner, suggesting that isoalantolactone induces apoptosis through intrinsic pathway. In addition, massive CL oxidation, reduction in MMP and cytochrome c release into cytosol in isoalantolactone-treated cells further support the above findings. These results are consistent with previous study where n-hexane fraction of roots of Inula recemosa reduced the MMP with increase expression of Bax and cytochrome c release in HL-6o cells .
Once cytochrome c is released to cytosol, it binds and activates caspase-9, which then results in the activation of other downstream caspases and ultimately caspase-3. Caspase-3 has been identified as a main executioner of apoptotic response inside the cells. Finally activated caspase-3 cleaved effector proteins including PARP, and induced DNA fragmentation in nucleus which eventually leads to cell death . In the present study, an increase in the cleaved caspase-3 has been observed in isoalantolactone-treated cells. These results demonstrate clearly that isoalantolactone induces apoptosis in PANC-1 cells through mitochondrial dysfunction and caspase-3 activation. It has been reported previously that increased intracellular ROS generation induces the cell cycle arrest at S phase [29, 30]. Our cell cycle analysis results clearly confirm these findings.
A number of previous studies have shown that the phytochemicals targeting ROS metabolism can selectively kill the cancer cells by raising the level of ROS above a toxic threshold [7, 8, 31]. As cancer cells contain higher level of basal endogenous ROS than normal cells , the toxic threshold value in cancer cells can be achieved faster compared to normal cells . In the present study, isoalantolactone showed strong growth inhibitory effect towards PANC-1 cells; however this growth inhibitory effect of isoalantolactone towards normal cells (COS-7) was significantly lower compared to the cancer cells. In addition, isoalantolactone did not cause any dectectable acute or chronic toxicity in liver and kidneys of CD1 mice in vivo at a dose of 100 mg/kg body weight. This selective toxicity of isoalantolactone between cancer cells and normal cells may be due to much lower level of endogenous ROS in normal cells than cancer cells. However, a detailed investigation of this selective cytotoxicity of isoalantolactone still needs to be performed in vivo.
In conclusion, our data demonstrated for the first time that isoalantolactone induced ROS-dependent apoptosis in PANC-1 cells through mitochondrial intrinsic pathway. Furthermore, the different effect of isoalantolactone between cancer cells and normal cells might be dependent on different level of endogenous ROS. Our results suggest that isoalantolactone may be a promising chemotherapeutic drug candidate for the treatment of pancreatic carcinoma. Further investigation is needed to validate the contribution of isoalantolactone to tumor therapy in vivo.
This work is supported by Ministry of Education, Pakistan and Chinese Scholarship Council, China.
The authors have declared that no competing interest exists.
1. Jemal A, Siegel R, Ward E. et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225-249
2. Yip-Schneider MT, Nakshatri H, Sweeney CJ. et al. Parthenolide and sulindac cooperate to mediate growth suppression and inhibit the nuclear factor-kappa B pathway in pancreatic carcinoma cells. Mol Cancer Ther. 2005;4:587-594
3. Awasthi N, Kirane A, Schwarz MA. et al. Smac mimetic-derived augmentation of chemotherapeutic response in experimental pancreatic cancer. BMC Cancer. 2011;11:15
4. Arlt A, Gehrz A, Muerkoster S. et al. Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death. Oncogene. 2003;22:3243-3251
5. Ou YQ, Zhu W, Li Y. et al. Aspirin inhibits proliferation of gemcitabine-resistant human pancreatic cancer cells and augments gemcitabine-induced cytotoxicity. Acta Pharmacol Sin. 2010;31:73-80
6. El-Sayyad HI, Ismail MF, Shalaby FM. et al. Histopathological effects of cisplatin, doxorubicin and 5-flurouracil (5-FU) on the liver of male albino rats. Int J Biol Sci. 2009;5:466-473
7. Schumacker PT. Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell. 2006;10:175-176
8. Fruehauf JP, Meyskens FLJr. Reactive oxygen species: a breath of life or death?. Clin Cancer Res. 2007;13:789-794
9. Lyss G, Knorre A, Schmidt TJ. et al. The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-kappaB by directly targeting p65. J Biol Chem. 1998;273:33508-16
10. Ghantous A, Gali-Muhtasib H, Vuorela H. et al. What made sesquiterpene lactones reach cancer clinical trials?. Drug Discov Today. 2010;15:668-78
11. Zhang S, Won YK, Ong CN. et al. Anti-cancer potential of sesquiterpene lactones: bioactivity and molecular mechanisms. Curr Med Chem Anticancer Agents. 2005;5:239-49
12. Pal HC, Sehar I, Bhushan S. et al. Activation of caspases and poly (ADP-ribose) polymerase cleavage to induce apoptosis in leukemia HL-60 cells by Inula racemosa. Toxicol In Vitro. 2010;24:1599-1609
13. Khan M, Yu B, Rasul A. et al. Jaceosidin induces apoptosis in U87 glioblastoma cells through G2/M phase arrest. Evid-based comp Alt Med. doi:10.1155/2012/703034
14. Trachootham D, Zhou Y, Zhang H. et al. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer Cell. 2006;10:241-252
15. Lv W, Sheng X, Chen T. et al. Jaceosidin induces apoptosis in human ovary cancer cells through mitochondrial pathway. J Biomed Biotechnol. 2008;2008:394802
16. Ling X, Zhou Y, Li SW. et al. Modulation of mitochondrial permeability transition pore affects multidrug resistance in human hepatocellular carcinoma cells. Int J Biol Sci. 2010;6:773-783
17. Ji YB, Qu ZY, Zou X. Juglone-induced apoptosis in human gastric cancer SGC-7901 cells via the mitochondrial pathway. Exp Toxicol Pathol. 2011;63:69-78
18. Wood CD, Thornton TM, Sabio G. et al. Nuclear localization of p38 MAPK in response to DNA damage. Int J Biol Sci. 2009;5:428-437
19. Ghatan S, Larner S, Kinoshita Y. et al. p38 MAP kinase mediates bax translocation in nitric oxide-induced apoptosis in neurons. J Cell Biol. 2000;150:335-347
20. Gomez-Lazaro M, Galindo MF, Melero-Fernandez de Mera RM. et al. Reactive oxygen species and p38 mitogen-activated protein kinase activate Bax to induce mitochondrial cytochrome c release and apoptosis in response to malonate. Mol Pharmacol. 2007;71:736-743
21. Lawrence NJ, McGown AT, Nduka J. et al. Cytotoxic Michael-type amine adducts of alpha-methylene lactones alantolactone and isoalantolactone. Bioor Med Chem Lett. 2001;11:429-431
22. Konishi T, Shimada Y, Nagao T. et al. Antiproliferative sesquiterpene lactones from the roots of Inula helenium. Biol Pharm Bull. 2002;25:1370-1372
23. Ding X, Zhu F, Li T. et al. Numb protects renal proximal tubular cells from puromycin aminonucleoside-induced apoptosis through inhibiting Notch signaling pathway. Int J Biol Sci. 2011;7:269-278
24. Jia YT, Wei W, Ma B. et al. Activation of p38 MAPK by reactive oxygen species is essential in a rat model of stress-induced gastric mucosal injury. J Immunol. 2007;179:7808-7819
25. Tsujimoto Y, Shimizu S. Role of the mitochondrial membrane permeability transition in cell death. Apoptosis. 2007;12:835-840
26. Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med. 2010;48:749-762
27. Ji YB, Gao SY, Ji CF. et al. Induction of apoptosis in HepG2 cells by solanine and Bcl-2 protein. J Ethnopharmacol. 2008;115:194-202
28. Ghatan S, Larner S, Kinoshita Y. et al. p38 MAP kinase mediates bax translocation in nitric oxide-induced apoptosis in neurons. J Cell Biol. 2000;150:335-347
29. Hsu SC, Kuo CL, Lin JP. et al. Crude extracts of Euchresta formosana radix induce cytotoxicity and apoptosis in human hepatocellular carcinoma cell line (Hep3B). Anticancer Res. 2007;27:2415-2425
30. Chiu TH, Lai WW, Hsia TC. et al. Aloe-emodin induces cell death through S-phase arrest and caspase-dependent pathways in human tongue squamous cancer SCC-4 cells. Anticancer Res. 2009;29:4503-4511
31. Lopez-Lazaro M. Dual role of hydrogen peroxide in cancer: possible relevance to cancer chemoprevention and therapy. Cancer Lett. 2007;252:1-8
32. Ho BY, Wu YM, Chang KJ. et al. Dimerumic acid inhibits SW620 cell invasion by attenuating HO-mediated MMP-7 expression via JNK/C-Jun and ERK/C-Fos activation in an AP-1-dependent manner. Int J Biol Sci. 2011;7:869-880
33. Ding H, Han C, Guo D. et al. Selective induction of apoptosis of human oral cancer cell lines by avocado extracts via a ROS-mediated mechanism. Nutr Cancer. 2009;61:348-356
Corresponding author: Tonghui Ma, Central Research Laboratory, Jilin University Bethune Second Hospital, Changchun 130041, P. R. China. Tel: +86-431-88796667. Fax: +86-431-88796667. E-mail: math108com